Former Bristol-Myers Squibb executive named CEO of immunotherapy company
April 25, 2019 at 07:00 AM EDT
The new CEO was the company's interim CEO for the past four months.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|